Search research articles
Contact Us
Filters
Showing results (1-10 of 155) with videos related to
Page
of 16
Sort By:
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
October 1, 1996
Second primary tumours (SPTs) after chemotherapy
G Cartei, S Liguori, G Tabaro, et al.
Anti-Cancer Drugs
|
January 1, 1996
A phase II study of oral fluorouracil for gastrointestinal cancer
F Cartei, G Cartei, T Giraldi, et al.
American Journal of Clinical Oncology
|
April 25, 2000
Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged
G Cartei, F Cartei, G Interlandi, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
April 1, 1996
Synthetic thymic fraction 5: effects of high dose administration on circulating lymphocytes in patients
G Cartei, G Sava, G Salerno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 1999
Cisplatin and gemcitabine in non-small-cell lung cancer
G Cartei, C Sacco, A Sibau, et al.
Anti-Cancer Drugs
|
November 1, 1996
Liver function tests and lidocaine metabolism (MEGX test) during i.v. CMF therapy in breast cancer
V Rizzi, B Cioschi, G Cartei, et al.
Medical and Pediatric Oncology
|
May 20, 1998
Poorly differentiated squamous cell carcinoma of the parotid gland in a 13-year-old girl
G Cartei, P Zorat, F Cartei, et al.
Journal of the National Cancer Institute
|
May 19, 1993
Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer
G Cartei, F Cartei, A Cantone, et al.
Journal of Chemotherapy (Florence, Italy)
|
January 12, 2012
Chronic anemia due to mitomycin C is drug dose-dependent, normocytic, progressive, related to erythropoietin levels and quantitatively predictable: implications for radiochemotherapy
G Cartei, E Colombrino, M C Sanzari, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma
R Rosso, T Mazzei, A Sobrero, et al.
Page
of 16
Search research articles
Search
Showing results (1-10 of 155) with videos related to
Sort By:
Page
of 16
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
October 1, 1996
Second primary tumours (SPTs) after chemotherapy
G Cartei, S Liguori, G Tabaro, et al.
Anti-Cancer Drugs
|
January 1, 1996
A phase II study of oral fluorouracil for gastrointestinal cancer
F Cartei, G Cartei, T Giraldi, et al.
American Journal of Clinical Oncology
|
April 25, 2000
Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged
G Cartei, F Cartei, G Interlandi, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
April 1, 1996
Synthetic thymic fraction 5: effects of high dose administration on circulating lymphocytes in patients
G Cartei, G Sava, G Salerno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 1999
Cisplatin and gemcitabine in non-small-cell lung cancer
G Cartei, C Sacco, A Sibau, et al.
Anti-Cancer Drugs
|
November 1, 1996
Liver function tests and lidocaine metabolism (MEGX test) during i.v. CMF therapy in breast cancer
V Rizzi, B Cioschi, G Cartei, et al.
Medical and Pediatric Oncology
|
May 20, 1998
Poorly differentiated squamous cell carcinoma of the parotid gland in a 13-year-old girl
G Cartei, P Zorat, F Cartei, et al.
Journal of the National Cancer Institute
|
May 19, 1993
Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer
G Cartei, F Cartei, A Cantone, et al.
Journal of Chemotherapy (Florence, Italy)
|
January 12, 2012
Chronic anemia due to mitomycin C is drug dose-dependent, normocytic, progressive, related to erythropoietin levels and quantitatively predictable: implications for radiochemotherapy
G Cartei, E Colombrino, M C Sanzari, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma
R Rosso, T Mazzei, A Sobrero, et al.
Page
of 16